Forward-Looking StatementThis press release contains forward-looking statements, substantial risks and uncertainties, including those discussed below and others in the 31st Amgen ‘s Form 10 – K for the year ended Found in December 2004 to be included, and Amgen periodic reports on Form 10-Q and Form 8-K. Amgen is providing this information at the time of publication of this press release and does not undertake to update any forward-looking statements in this document as result of new information, future events or otherwise.
Although anemia is a common and often debilitating side effect of chemotherapy, it is often not recognized and under-treated frequently. Amgen 42 % of patients with a hemoglobin of less than the recommended target of 11 to 12 g / dL in the National Comprehensive Cancer Network guidelines for ‘Cancer and Treatment Anemia ‘with never erythropoietin therapy treats.He added that provide help provide assistance to malaria in Africa, as well as as target, fight to strengthen trade between the U.S. And the continent . J Courtesy of you , the whole Kaiser Daily Health Policy Report view, search the archives or sign up for mail service at emperors Daily Health policy coverage strongly supports emperor network. A free service from The Henry J. Published. Kaiser Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation.